SUMMARY Systemic lupus erythematosus (SLE) was diagnosed in 31 black Zimbabweans over a six year period. Renal involvement (71%) was more common and photosensitivity (16%) and serositis (23%) less common than in the United States. Lymphopenia (48%) was the commonest haematological abnormality. Unusual complications included subarachnoid haemorrhage, cardiac rhythm disturbance, portal and superior mesenteric vein thrombosis, and a non-Hodgkin lymphoma. Tuberculosis was a common differential diagnosis that was difficult to exclude. Nine patients (29%) died within one year of diagnosis. SLE is being recognised more commonly in Zimbabwe.
female and one male, whose average age at diagnosis was 28 years (range years). Of these 31 patients, 22 stated that they lived in either Bulawayo or Harare and the remaining nine were referred from outlying districts. Table 1 lists the ARA criteria and the relative frequency of each in our patients and in the multicentre American study on which the revision of the criteria was based.9 SKIN In addition to the rashes listed as criteria, nonspecific rashes were seen in six patients (two macular, two maculopapular, and two urticarial), and one patient had longstanding psoriasis. Alopecia and Raynaud's phenomenon occurred in 10 and five patients respectively. Skin biopsies were performed in two patients and showed changes compatible with SLE.
CLINICAL FEATURES

VASCULAR FEATURES
Vasculitic lesions of the peripheries were seen in five patients, one of whom suffered a subarachnoid haemorrhage presumably due to vasculitis. Deep months, but only 5-1 months in those with renal involvement, this seems unlikely to apply to our series.
Photosensitivity (16%) and serositis (23%) were relatively infrequent in our patients. Previous studies in black Africans 7 have not recorded the incidence of photosensitivity, and it is possible that melanin has a protective role. Lymphopenia (less than 1500/mm3 (1-5 x 109/l) on two or more occasions) is a lesser known manifestation of SLE but was the most common haematological abnormality (48%) in our patients. Since two patients were treated for tuberculosis before developing SLE this raises the possibility of drug induced lupus erythematosus, but the marked renal involvement in both cases makes this unlikely. Although the development of tuberculosis in any patient was not proved, Systemic lupus erythematosus in Zimbabwe 647 one patient known to have SLE and two others, at the time undiagnosed, received antituberculous therapy because of their critical condition and the clinical possibility of tuberculosis. Feng and Tan report a tuberculosis prevalence rate of 5% in their 311 SLE patients in Singapore,'3 and three of the 30 patients reported by Seedat and Pudifin developed tuberculosis while receiving immunosuppressive therapy. 6 Feng and Tan emphasise the difficulty in diagnosing particularly extrapulmonary tuberculosis in patients with SLE,13 and diagnostic confusion between these two diseases will certainly continue in areas where tuberculosis is prevalent, marked cachexia being a common presentation of both. Septic arthritis occurred in one patient receiving prednisolone and another not receiving treatment and illustrates the importance of a high level of suspicion for this condition in patients known to have SLE.
In 1978 Green et al found 14 cases in the literature of lymphoma associated with SLE and reported four of their own. 14 In 12 of these cases, as in our patient, SLE preceded the lymphoma. The lymphoma was of the non-Hodgkin variety in seven of these 12 cases. Our patient, and nine of the 12 reported by Green et al,14 received no immunosuppressive therapy apart from corticosteroids, which are widely used in other conditions and not related to the development of lymphoid tumours. Suppressor T cell dysfunction allowing abnormal B cell proliferation in response to extrinsic or autoantigens has been suggested as a common factor underlying the association, with viral infections possibly playing a role in initiating the lymphoma.'4 Despite the frequent occurrence of benign lymphadenopathy in SLE patients (39% in our series), previous authors have stressed the importance of early lymph node biopsy.15 Spontaneous regression of low grade non-Hodgkin lymphomas is quite common.'6 Venous and arterial thromboses are common in SLE patients with circulating lupus anticoagulant,'7 so named for its ability to prolong phospholipid dependent coagulation tests with no correction on adding normal plasma, rather than from any propensity to cause excessive bleeding.'8 Isolation of lupus anticoagulant is difficult but its presence is highly correlated with raised anticardiolipin levels, and the latter may be an indicator of SLE patients at high risk for thrombosis.'8 Both our patients with thromboses were VDRL negative, but this test may not be sufficiently sensitive.
Bulawayo and Harare, with its satellite town of Chitungwiza, had a combined population of 1.24 million in 1982.19 Thus the ascertainment of 22 cases from these towns during the six year period 1979-84 gives an estimated incidence of three per million per year. This figure might be an underestimate to the extent that it is based on attenders at the study hospitals. Conversely, the incidence could be inflated by patients moving into the towns as a consequence of SLE development.
Although still an uncommon disease, SLE is being recognised more frequently in black Africans, and this paper illustrates the wide range of manifestations and relative severity of the disease in Zimbabwe. In 1984 12 of our 31 patients (39%) presented for the first time. This may reflect a greater clinical awareness or changing patterns of disease.
